U.S. Consumer Services Stock News

NasdaqGS:ANGI
NasdaqGS:ANGIInteractive Media and Services

Angi (ANGI) Valuation Check After Weak Q4 Results And Sharp Share Price Drop

Angi (ANGI) is back in focus after its fourth quarter 2025 results showed a 10.1% year on year revenue decline, softer service requests, and an earnings shortfall that coincided with a sharp share price drop. See our latest analysis for Angi. That weak quarter helped accelerate an existing trend, with a 7 day share price return of 31.65% and a 30 day share price return of 35.25%, contributing to a 1 year total shareholder return of 55.98% and a 5 year total shareholder return of 94.72%. This...
NYSE:CMI
NYSE:CMIMachinery

Cummins Reshapes Portfolio As Engines Strengthen And Clean Tech Strategy Shifts

Cummins (NYSE:CMI) is divesting its remaining interest in Atmus Filtration Technologies as part of a broader transformation of its portfolio. The company is reviewing its Accelera segment after deteriorating market conditions and a halt to new commercial activity in its electrolyzer business. Cummins is rolling out new advanced engine platforms and expanding in power systems, signaling a shift in its product focus. Cummins, long known for its engines and power solutions, is reshaping where...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Wynn Resorts Advances UAE Flagship As International Mix And Valuation Diverge

Wynn Resorts (NasdaqGS:WYNN) reported the topping out of the Wynn Al Marjan Island tower in the UAE, a key phase in its first Middle East project, with opening targeted for 2027. Management highlighted a shift toward greater international diversification, with an expectation that more than half of future revenues will come from markets outside the U.S. The company maintained its leading position for Forbes Travel Guide Five-Star awards and is proceeding with upgrades and renovations across...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

Is It Time To Reconsider UMB Financial (UMBF) After Recent Share Price Swings?

If you are wondering whether UMB Financial at around US$128.77 is offering fair value or a potential bargain, this article walks through what the numbers actually say. The share price has had mixed short term moves, with a 4.1% decline over the last 7 days, a 6.7% gain over 30 days, and returns of 10.6% year to date, 16.8% over 1 year, 48.1% over 3 years and 73.1% over 5 years. These returns sit against a backdrop of ongoing sector wide attention on US regional banks, including how they...
NYSE:AS
NYSE:ASLuxury

Amer Sports (AS) Is Up 6.1% After Salomon Secures 2026 Olympic Deal And DTC Expansion - What's Changed

Amer Sports recently highlighted that its flagship brands Arc’teryx and Salomon have been gaining relevance across U.S. and international markets, supported by expanding direct-to-consumer channels and retail rollouts. An interesting angle is Salomon’s first official Olympic Games partnership for the 2026 Milano Cortina Winter Olympics, which the company is using to deepen consumer engagement through immersive experiences and product innovation. We’ll now examine how this brand momentum,...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Kodiak AI Marine Corps Deal Tests Dual Use Autonomy Investment Case

Kodiak AI (NasdaqGM:KDK) has secured a new contract with the U.S. Marine Corps to integrate its autonomous driving technology into military ground vehicles. The agreement extends Kodiak's AI trucking platform into defense use cases, focusing on unstructured and potentially high risk terrains. The deal introduces a new revenue channel for Kodiak AI and deepens its role as a technology partner in U.S. national security programs. Kodiak AI is stepping further into the public sector at a time...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s New Therapies Surpass US$1 Billion In Sales Might Change The Case For Investing In BIIB

In early February 2026, Biogen reported fourth-quarter 2025 results showing quarterly sales of US$521.2 million and full-year revenue of US$9.89 billion, alongside a quarterly net loss and lower annual earnings versus 2024. Despite the earnings pressure, management highlighted that newer therapies such as Leqembi, Skyclarys, Xerxuve and Calcadi collectively exceeded US$1 billion in 2025 revenue, underlining Biogen’s increasing reliance on its emerging portfolio rather than legacy...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Does Daktronics' (DAKT) New CEO-Director Dual Role Reshape Its Long-Term Execution Priorities?

On February 1, 2026, Daktronics appointed Ramesh Jayaraman as President, Chief Executive Officer, and Board member, while former CEO Reece A. Kurtenbach resigned from the Board and interim CEO Bradley T. Wiemann began an advisory transition period ahead of retirement. This coordinated leadership handover tightens the link between management and the Board, potentially influencing how Daktronics executes its growth, efficiency, and capital allocation plans. Now, we’ll examine how Jayaraman’s...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

Insider Selling At Ollie's Raises Questions On Valuation And Targets

Executive Chairman John Swygert of Ollie's Bargain Outlet Holdings (NasdaqGM:OLLI) recently sold company shares, extending a pattern of insider selling. The company has seen repeated insider sales over the past year with no reported insider purchases in the same period. This selling activity may draw attention from investors who monitor insider trading as one of several sentiment indicators. Ollie's Bargain Outlet Holdings, traded under NasdaqGM:OLLI, operates discount retail stores that...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

How MannKind’s First Pediatric Afrezza Trial (INHALE-1ST) At MannKind (MNKD) Has Changed Its Investment Story

MannKind Corporation recently reported that it has enrolled the first pediatric patient in INHALE-1ST, a clinical study evaluating the safety and efficacy of Afrezza (insulin human) Inhalation Powder initiated soon after type 1 diabetes diagnosis in youth aged 10 and above, used alongside once-daily basal insulin. This milestone builds on the FDA’s October 2025 acceptance of a supplemental Biologics License Application for pediatric Afrezza, positioning the inhaled insulin as a potential...
NYSE:AHR
NYSE:AHRHealth Care REITs

Can American Healthcare REIT's (AHR) Interim CEO Appointment Quietly Reinforce Its Long-Term Real Estate Strategy?

Earlier this month, American Healthcare REIT, Inc. announced that Chief Executive Officer and President Danny Prosky took a medical leave of absence on February 3, 2026, with Chairman Jeffrey T. Hanson stepping in as Interim CEO and President to work with the senior leadership team on maintaining operations and existing priorities. This leadership change comes as the company highlights its diversified healthcare real estate portfolio and sizeable 2025 acquisitions, underscoring an emphasis...
NYSE:RH
NYSE:RHSpecialty Retail

RH Expands Outdoor Sourcebook As Investors Weigh Growth And Risks

RH (NYSE:RH) has introduced its 2026 RH Outdoor Sourcebook, featuring an expanded range of outdoor collections. The company announced the new Sourcebook as a major addition to its outdoor offering, aimed at the upcoming 2026 season. RH, known for its high end home furnishings and design driven collections, continues to build out its brand around whole home concepts that include indoor and outdoor spaces. For investors, a broader outdoor lineup can matter because it ties into consumer...
NYSE:COMP
NYSE:COMPReal Estate

Is It Time To Reassess Compass (COMP) After The Recent Share Price Pullback?

If you are wondering whether Compass shares still offer value after their recent run, this article will walk through what the current price might be implying about the business. The stock recently closed at US$10.41, with a 7 day return of a 15.2% decline, a 30 day return of a 15.4% decline, a year to date return of a 0.9% decline, and a 1 year return of 31.3%, while the 3 year return is very large. Recent news coverage around Compass has focused on its position within the US real estate...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

Kimberly-Clark’s Kenvue Deal Shifts Growth Story Toward Health Brands

Kimberly-Clark shareholders have approved the acquisition of Kenvue. The deal brings brands such as Aveeno, Band-Aid, and Tylenol into the Kimberly-Clark portfolio. The transaction positions NasdaqGS:KMB for a broader presence in global health and wellness products. For you as an investor, this vote signals that Kimberly-Clark is committing to a much larger footprint in consumer health, in addition to its existing personal care and tissue business. The shares last closed at $109.41, with a...
NYSE:SNDR
NYSE:SNDRTransportation

What Schneider National (SNDR)'s EV Milestone and Citigroup Downgrade Means For Shareholders

In recent days, Schneider National announced it has become the first major carrier to surpass 10 million zero-emission miles with its nearly 100 Freightliner eCascadia battery-electric trucks, underscoring its focus on lower-emission freight operations. The milestone, alongside ongoing investments in technology and driver training, highlights how Schneider is using electrification to cut emissions and improve operating efficiency while a major bank’s downgrade raises fresh questions about...
NYSE:VZ
NYSE:VZTelecom

Why Verizon (VZ) Is Up 5.8% After Major Consumer Leadership Shake-Up And Job Cuts - And What's Next

Verizon Communications Inc. recently announced that Sowmyanarayan Sampath will step down as CEO of the Verizon Consumer Group at the end of the first quarter of 2026, with Chief Transformation Officer Alfonso Villanueva taking over on an interim basis as the company cuts 13,000 jobs and shifts 179 corporate-owned stores to franchises. These leadership and organizational changes mark a major step in Verizon’s turnaround plan under new CEO Dan Schulman, aligning consumer operations more...
NYSE:AGBK
NYSE:AGBKBanks

AGI (NYSE:AGBK) Valuation Check After Recent 7.7% Share Price Move

AGI stock: what the latest move means for investors AGI (AGBK) gained 7.7% in the latest session, drawing attention to the Brazil based financial services provider and its cloud and AI enabled lending and insurance platform serving social security and payroll clients. See our latest analysis for AGI. The 7.7% 1 day share price return lifts AGI to $11.00, while the year to date share price return of 2.3% suggests early momentum that investors may see as a shift in sentiment around its Brazil...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

Is CleanSpark (CLSK) Pricing Reflecting Recent Share Pullback And Bitcoin Sentiment Swings

If you are looking at CleanSpark and wondering whether the recent share price makes sense, this article will walk through what that could mean for the stock's current value. The share price closed at US$9.85 most recently, with returns of a 2.3% decline over 7 days, a 26.2% decline over 30 days, a 14.7% decline year to date, a 6.2% decline over 1 year and a very large 3 year gain that compares to a 72.9% decline over 5 years. Recent coverage around CleanSpark has focused on its position as a...
NYSE:PCOR
NYSE:PCORSoftware

Procore Technologies (PCOR) Q4 Loss Per Share Narrows And Tests Profitability Narratives

Latest FY 2025 results snapshot Procore Technologies (PCOR) has wrapped up FY 2025 with Q4 revenue of US$349.1 million, a basic EPS loss of US$0.25 per share and net income loss excluding extra items of US$37.6 million. These figures help shape how investors assess its path toward profitability. The company reported quarterly revenue of US$302.0 million in Q4 2024 and US$349.1 million in Q4 2025, while basic EPS shifted from a loss of US$0.42 to a loss of US$0.25 over the same period. This...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

Power Solutions International (PSIX) Is Up 22.0% After Beating Q3 Sales And Earnings Estimates - Has The Bull Case Changed?

Power Solutions International recently reported third-quarter results showing sales increasing to US$203.8 million from US$125.8 million a year earlier, while earnings rose to US$27.6 million, both ahead of analyst expectations. This combination of strong top-line and bottom-line growth, coupled with substantial positive surprises versus forecasts, has drawn fresh attention from analysts and investors. We’ll now look at how this strong third-quarter sales surge reshapes Power Solutions...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Is It Time To Reassess Corpay (CPAY) After Mixed Share Price Performance?

If you are wondering whether Corpay at around US$337.12 is a bargain or a stock to be cautious about, you will want to look closely at what today’s price actually implies about its value. The share price performance has been mixed, with a 4.8% decline over the last 7 days, a 2.9% gain over the last 30 days, a 12.2% return year to date, and a 10.7% decline over the past year, while the 3 year and 5 year returns sit at 57.8% and 23.3% respectively. Recent coverage of Corpay has focused on its...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

A Look At CECO Environmental (CECO) Valuation After Record US$135m Emissions Management Order

CECO Environmental (CECO) recently secured a record order worth over US$135 million for an emissions management system at a Texas natural gas power plant, drawing fresh attention to the stock and its role in pollution control. See our latest analysis for CECO Environmental. The record Texas contract and expanded US$700.0m credit facility have arrived alongside strong share price momentum, with a 20.42% 1 month share price return and a very large 1 year total shareholder return that signals...
NasdaqGS:MWH
NasdaqGS:MWHConstruction

A Look At SOLV Energy (MWH) Valuation After Recent 4.6% Share Price Move

SOLV Energy (MWH) has caught investor attention after a single day move of 4.6%, prompting a closer look at how its current share price compares with its earnings power and value indicators. See our latest analysis for SOLV Energy. The 4.6% 1 day share price return to $32.34 sits alongside a 5.5% year to date share price return, suggesting momentum has recently picked up as investors reassess SOLV Energy’s earnings profile and perceived risk. If this move has you thinking about other...
NYSE:WEX
NYSE:WEXDiversified Financial

Is It Time To Reconsider WEX (WEX) After Its Recent Share Price Pause?

If you are wondering whether WEX at around US$157 per share still offers value, looking closely at what you are paying for each dollar of its business is a useful place to start. The stock has been relatively muted recently, with a 0.8% decline over the last 7 days and a 2.3% decline over the last 30 days, while year to date it is up 6.3% and 1 year returns sit at 1.9% against weaker 3 year and 5 year returns of 18.0% and 28.7% declines. Recent coverage of WEX has focused on keeping...